111 related articles for article (PubMed ID: 33962997)
1. Skeletal system as a rare metastatic site in patients with ovarian carcinoma.
Ak N; Minareci Y; Saip P
Int J Gynecol Cancer; 2021 Aug; 31(8):1125-1131. PubMed ID: 33962997
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of early versus late onset of bone metastasis in patients with carcinoma of the ovary, peritoneum and fallopian tube.
Sehouli J; Olschewski J; Schotters V; Fotopoulou C; Pietzner K
Ann Oncol; 2013 Dec; 24(12):3024-8. PubMed ID: 24130264
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
4. Inaugural bone metastases in non-small cell lung cancer: a specific prognostic entity?
Deberne M; Ropert S; Billemont B; Daniel C; Chapron J; Goldwasser F
BMC Cancer; 2014 Jun; 14():416. PubMed ID: 24913188
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and prognostic factors in patients with bone metastases from non-small cell lung cancer.
Wu XT; Zhou JW; Pan LC; Ge T
J Int Med Res; 2020 May; 48(5):300060520925644. PubMed ID: 32425092
[TBL] [Abstract][Full Text] [Related]
6. Cytoreductive surgery for stage IV epithelial ovarian cancer.
Zang RY; Zhang ZY; Cai SM; Li ZT; Chen J; Tang MQ; Liu Q
J Exp Clin Cancer Res; 1999 Dec; 18(4):449-54. PubMed ID: 10746968
[TBL] [Abstract][Full Text] [Related]
7. The outcome of prostate cancer patients treated with curative intent strongly depends on survival after metastatic progression.
Pascale M; Azinwi CN; Marongiu B; Pesce G; Stoffel F; Roggero E
BMC Cancer; 2017 Sep; 17(1):651. PubMed ID: 28923109
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
[TBL] [Abstract][Full Text] [Related]
9. Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma.
Di Nunno V; Mollica V; Schiavina R; Nobili E; Fiorentino M; Brunocilla E; Ardizzoni A; Massari F
Clin Genitourin Cancer; 2020 Apr; 18(2):e83-e90. PubMed ID: 31753738
[TBL] [Abstract][Full Text] [Related]
10. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and prognostic factors for gastric cancer patients with bone metastasis.
Mikami J; Kimura Y; Makari Y; Fujita J; Kishimoto T; Sawada G; Nakahira S; Nakata K; Tsujie M; Ohzato H
World J Surg Oncol; 2017 Jan; 15(1):8. PubMed ID: 28061855
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
13. Distant metastases in ovarian carcinoma.
Cormio G; Rossi C; Cazzolla A; Resta L; Loverro G; Greco P; Selvaggi L
Int J Gynecol Cancer; 2003; 13(2):125-9. PubMed ID: 12657111
[TBL] [Abstract][Full Text] [Related]
14. Stage IV ovarian cancer: impact of surgical debulking.
Curtin JP; Malik R; Venkatraman ES; Barakat RR; Hoskins WJ
Gynecol Oncol; 1997 Jan; 64(1):9-12. PubMed ID: 8995540
[TBL] [Abstract][Full Text] [Related]
15. Comparison between solitary and multiple skeletal metastatic lesions of breast cancer patients.
Koizumi M; Yoshimoto M; Kasumi F; Ogata E
Ann Oncol; 2003 Aug; 14(8):1234-40. PubMed ID: 12881385
[TBL] [Abstract][Full Text] [Related]
16. Sites of distant metastases and overall survival in ovarian cancer: A study of 1481 patients.
Deng K; Yang C; Tan Q; Song W; Lu M; Zhao W; Lou G; Li Z; Li K; Hou Y
Gynecol Oncol; 2018 Sep; 150(3):460-465. PubMed ID: 30001833
[TBL] [Abstract][Full Text] [Related]
17. Effect of glandular metastases on overall survival of patients with metastatic clear cell renal cell carcinoma in the antiangiogenic therapy era.
Gravis G; Chanez B; Derosa L; Beuselinck B; Barthelemy P; Laguerre B; Brachet PE; Joly F; Escudier B; Harrison DJ; Laird A; Vasudev N; Ralph C; Larkin J; Lote H; Salem N; Walz J; Thomassin J; Sfumato P; Stewart GD; Boher JM;
Urol Oncol; 2016 Apr; 34(4):167.e17-23. PubMed ID: 26670200
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
Li X; Zhang X; Liu J; Shen Y
BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of the controlling nutritional status (CONUT) score in epithelial ovarian cancer.
Li Y; Zhang C; Ji R; Lu H; Zhang W; Li LL; Liu R; Qian H; He A
Int J Gynecol Cancer; 2020 Jan; 30(1):74-82. PubMed ID: 31822507
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of the prognostic significance of refinement and stratification of distant metastasis status in 1016 cases of nasopharyngeal carcinoma].
Pan CC; Lu J; Chen P; Li X; Jin YD; Zhao M; Xia YF; Wu PH
Zhonghua Zhong Liu Za Zhi; 2013 Aug; 35(8):595-9. PubMed ID: 24314217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]